Tech-Enhanced Care Reduces Depression in Cancer Patients
The Intersection of Technology and Psycho-Oncology Care
Jesse Fann, MD, MPH, provided insights on the SCOPE trial, which evaluated technology-enhanced collaborative care for depression in patients undergoing active cancer treatment.
The SCOPE trial, led by Dr. Jesse Fann, demonstrates how technology-enabled collaborative care effectively treats depression in active cancer patients. This breakthrough integrates mental health support into oncology treatment, addressing a critical gap in psycho-oncology. Results suggest digital tools can significantly improve patient outcomes during cancer therapy.
Original Article
Read full article on Cancer NetworkExplore More
Related News
7 Ways Technology Helps Auto Dealerships Succeed
NADA Home Page | NADA · 2026.04.14
2026 Technology Industry Trends
2026.04.14
Inspira Technologies Initiates AME Technology Implementation with Major U.S. Customer
2026.04.14
NYC Office of Technology and Innovation
Welcome to NYC.gov | City of New York · 2026.04.14
What is blockchain technology simple explanation
Blockchain Council · 2026.04.14
Can blockchain technology redefine corporate governance?
Devdiscourse · 2026.04.14